Navigation Links
Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants
Date:4/27/2011

warrants, the Company's intentions regarding the use of proceeds, and other risk factors listed or described from time to time in the Company's filings with the SEC, including, without limitation, its most recent filings on Forms 10-K, 10-Q and 8-K.  Except as required by law, the Company does not intend to update any of the statements in this press release upon further developments.

Media Contact:

Dan Eramian
T: 206.272.4343
C: 206.854.1200
F: 206.272.4434
E: deramian@ctiseattle.com
www.celltherapeutics.com/media.htm

Investors Contact:

Ed Bell
T: 206.282.7100
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.celltherapeutics.com/investors


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... Research and Markets ( ... the  "Patient Handling Equipment Market by Product, ... End User - Global Forecast to 2019" ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The global patient ... potential for the next five years. The ...
(Date:9/12/2014)... -- ViewRay™, a privately held medical device company, announced ... the world,s first and only MRI-guided radiation therapy system, ... American Society for Radiation Oncology (ASTRO) being held September ... With ViewRay,s recent announcements of the world,s first on-table ... the first patient treated at the University of Wisconsin ...
(Date:9/12/2014)... Ga. , Sept. 12, 2014  WellStar Paulding ... and became the second in the U.S. ... apnea.  As part of WellStar Health System, Paulding Hospital ... offering the latest treatments and solutions. Inspire ... apnea in patients who are unable to use traditional ...
Breaking Medicine Technology:Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market - Forecast to 2019 2Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market - Forecast to 2019 3ViewRay to Showcase World's Only MRI-Guided Radiation Therapy System In Clinical Use at Largest Radiation Oncology Meeting 2ViewRay to Showcase World's Only MRI-Guided Radiation Therapy System In Clinical Use at Largest Radiation Oncology Meeting 3WellStar Pioneers New Sleep Apnea Treatment 2
... Reportlinker.com announces that a new market research report ... Cardiac Assist Devices - Global Pipeline Analysis, Opportunity ... http://www.reportlinker.com/p0330209/Cardiac-Assist-Devices---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html Cardiac Assist ... Market Forecasts to 2016 Summary ...
... 18, 2010 Former pharmaceutical representative Jeffrey Bethune today ... Bristol-Myers Squibb Company (BMS), charging the giant drug corporation ... law firm of Joseph, Herzfeld, Hester & Kirschenbaum LLP ... in excess of 40 hours a week but received ...
Cached Medicine Technology:Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 11Bristol-Myers Squibb Sued for Denying Employees Overtime Pay 2
(Date:9/15/2014)... September 15, 2014 PhySynergy, LLC, ... another new client partnership. PhySynergy will assume management ... this month. In addition to bringing strong leadership ... service capacity and anesthesia resources, by tapping into ... , “As we continue to invest in technologies ...
(Date:9/15/2014)... 15, 2014 Final Cut Pro X ... have announced a new Template the Qube Theme from Pixel ... a wide variety quality themes and the Qube theme adds ... Christian Austin, Pixel Film Studios CEO. “Qube theme has a ... Qube features intuitive controls that allow particle randomization, background color, ...
(Date:9/14/2014)... Petersburg, FL (PRWEB) September 15, 2014 Skin ... external factors like sun damage and not moisturizing properly. However, ... if skin has been cared for. , Two main reasons ... 2) Loss of hyaluronic acid in the skin , During ... and both of these are responsible for important moisture retention ...
(Date:9/14/2014)... Proper oral care requires about two ... found a way to teach children to brush their ... toothbrush encourages an effective brushing habit by ensuring that ... without overbrushing, eliminating guesswork and promoting independence and proper ... suitable for all children, and producible in design variations. ...
(Date:9/14/2014)... September 14, 2014 Top10BestSEOHosting.com always ... evaluating many web host suppliers carefully, the site ... and GoDaddy are the Best WordPress Hosting suppliers ... famous as a top web hosting provider, and ... is a web hosting provider known for its ...
Breaking Medicine News(10 mins):Health News:PhySynergy Wins Contract to Revive Anesthesia Services for Regional Hospital 2Health News:Announcing the Release of a New Template for Final Cut Pro X, The Qube Theme from Pixel Film Studios 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2
... IRVINE, Calif., Oct. 9 DogChannel.com, the premier,online destination ... Medical,Conditions section, where visitors can find what may be ... The symptom list, located at http://www.DogChannel.com/medical ... Rugh, DVM, Ph.D. of,Rocheport, Missouri. The section contains the ...
... Analysis of 38 studies found painkillers showed protective effect ... drugs (NSAIDs) are associated with a reduced risk for ... findings aren,t an invitation for all women to start ... don,t want that to happen here, for people to ...
... 9 The National Academy of,Neuropsychology (NAN) will be ... Conference to be held October 22nd,through 25th at The ... New York.,The event will kick off with a full ... October 21, which includes an athlete panel,featuring former NHL ...
... CRME TSX: COM VANCOUVER, Oct. ... TSX: COM) today announced that it has been ... that an End of Review,meeting with the U.S. ... November 14th, 2008 regarding the New Drug Application ...
... Tournament to be held at Woodmont,Country Club on Oct. ... Sandler,and his wife, Froma, are still dealing with the ... disease of unknown origin that has no,cure. Lisa died ... The Sandlers have turned their grief into action as ...
... The following was,released by the U.S. ... ceremony for the Alzheimer,s,Awareness 42-cent social awareness ... Rockefeller Neurosciences Institute,s http://www.brni.org new,research ... D. Rockefeller IV, U.S. Postal Service ...
Cached Medicine News:Health News:DogChannel.com Launches Online Guide to Dog Medical Conditions 2Health News:NSAIDs Might Lower Breast Cancer Risk 2Health News:NSAIDs Might Lower Breast Cancer Risk 3Health News:National Academy of Neuropsychology to Focus on Effects of Sports Concussions at 2008 Conference 2Health News:Cardiome Provides Regulatory Update 2Health News:Cardiome Provides Regulatory Update 3Health News:Parents Host Golf Tournament to Fund Cure for Disease That Claimed Daughter's Life 2Health News:Parents Host Golf Tournament to Fund Cure for Disease That Claimed Daughter's Life 3Health News:Postal Service to Issue Alzheimer's Awareness Stamp 2
Free Estriol (E3) RIA Reproductive Hormones 024-IDC-2000...
Prolactin EIA Reproductive Markers 025-BC-1037...
... (17aOHP) is produced by both the ... has relatively little progestational activity, it ... it is the,immediate precursor to 11-desoxycortisol ... 21-hydroxylation of 17aOHP,measurement of 17aOHP is ...
FSH EIA Reproductive Markers 025-BC-1029 Follicle Stimulating Hormone...
Medicine Products: